Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Fernando DeZarraga"'
Pembrolizumab activity in patients with Fanconi anemia repair pathway competent and deficient tumors
Autor:
Miguel A. Villalona-Calero, John P. Diaz, Wenrui Duan, Zuanel Diaz, Eric D. Schroeder, Santiago Aparo, Troy Gatcliffe, Federico Albrecht, Siddhartha Venkatappa, Victor Guardiola, Sara Garrido, Muni Rubens, Fernando DeZarraga, Hao Vuong
Publikováno v:
Biomarker Research, Vol 10, Iss 1, Pp 1-11 (2022)
Abstract Background Given the observed antitumor activity of immune-checkpoint-inhibitors in patients with mismatch-repair deficient (MSI-H) tumors, we hypothesized that deficiency in homologous-recombination-repair (HRR) can also influence susceptib
Externí odkaz:
https://doaj.org/article/638687a2c44a4b188f5880b1264f5ad8
Autor:
Michael D. Chuong, Roberto Herrera, Adeel Kaiser, Muni Rubens, Tino Romaguera, Diane Alvarez, Rupesh Kotecha, Matthew D. Hall, James McCulloch, Antonio Ucar, Fernando DeZarraga, Santiago Aparo, Sarah Joseph, Horacio Asbun, Ramon Jimenez, Govindarajan Narayanan, Alonso N. Gutierrez, Kathryn E. Mittauer
Publikováno v:
Frontiers in Oncology, Vol 12 (2022)
BackgroundRadiation therapy (RT) dose for inoperable pancreatic ductal adenocarcinoma (PDAC) has historically been non-ablative to avoid injuring gastrointestinal (GI) organs at risk (OARs). Accruing data suggest that dose escalation, in select patie
Externí odkaz:
https://doaj.org/article/6344dc0393954b6fb466ffa2ab20e626
Autor:
Catherine F. Welsh, Orlando Silva, Fernando DeZarraga, Isildinha M. Reis, Pedro Velez, Jodeen Powell, Judith Hurley, Carmen Gomez, Philomena Doliny
Publikováno v:
Clinical breast cancer. 5(6)
To evaluate the effectiveness and safety of weekly docetaxel/carboplatin as primary systemic therapy (PST) for locally advanced breast cancer, we conducted a phase II study. Forty-four patients with HER2-negative locally advanced or inflammatory brea